| Date Filed | Type | Description |
| 08/23/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 08/11/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/04/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 07/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 05/15/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 04/14/2023 |
8-K
| Quarterly results |
| 04/14/2023 |
424B2
| Form 424B2 - Prospectus [Rule 424(b)(2)]: |
| 04/06/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 04/04/2023 |
4
| Silva Francisco (VP of Research and Development) has filed a Form 4 on BioRestorative Therapies, Inc.|
Txns:
| Bought 747 shares
@ $3.56, valued at
$2.7k
|
|
| 03/28/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 03/22/2023 |
4
| Silva Francisco (VP of Research and Development) has filed a Form 4 on BioRestorative Therapies, Inc.|
Txns:
| Paid exercise price by delivering 6,729 shares
@ $2.92, valued at
$19.6k
|
|
| 03/22/2023 |
4
| ALSTODT LANCE (President, CEO, COB) has filed a Form 4 on BioRestorative Therapies, Inc.|
Txns:
| Paid exercise price by delivering 6,729 shares
@ $2.92, valued at
$19.6k
|
|
| 02/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/27/2023 |
4
| ALSTODT LANCE (President, CEO, COB) has filed a Form 4 on BioRestorative Therapies, Inc.|
Txns:
| Paid exercise price by delivering 374 shares
@ $2.99, valued at
$1.1k
|
|
| 02/14/2023 |
SC 13G/A
| Auctus Fund Management LLC reports a 9.9% stake in BioRestorative Therapies, Inc. |
| 02/13/2023 |
S-3/A
| Form S-3/A - Registration statement under Securities Act of 1933: [Amend] |
| 02/07/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 02/07/2023 |
SC 13G/A
| Hudson Bay Capital Management LP reports a 0% stake in BioRestorative Therapies, Inc. |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/30/2023 |
4
| ALSTODT LANCE (President, CEO, COB) has filed a Form 4 on BioRestorative Therapies, Inc.|
Txns:
| Bought 200 shares
@ $3.01, valued at
$602 |
|
| 01/24/2023 |
4
| ALSTODT LANCE (President, CEO, COB) has filed a Form 4 on BioRestorative Therapies, Inc.|
Txns:
| Bought 100 shares
@ $3.1, valued at
$310
Bought 100 shares
@ $3.17, valued at
$317 |
|
| 01/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
8-K
| Quarterly results |
| 12/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/09/2022 |
8-K
| Quarterly results |
| 11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|